SUMMARY Five patients with melting of the cornea in association with rheumatoid arthritis are described. The arthritis was often inactive and without systemic manifestations, in contrast to that seen in association with scleritis. In 3 there was evidence of reduced tear formation, but in none was tear production absent. In 3 patients the lesions healed during treatment with azathioprine or penicillamine.
over any of the joints. Investigations showed a normal plasma viscosity, haemoglobin, and white blood count. Rose-Waaler and latex tests were negative, as were tests for antinuclear factor and other autoantibodies; no LE cells were found. X-rays showed gross changes of rheumatoid arthritis.
In November 1974 she had been seen elsewhere with a complaint of dryness of the eyes, but not of the mouth, and was given artificial tears. In January 1975 the corrected visual acuity was 6/60 in the right eye and 6/36 in the left; there was some soreness and irritation of both eyes, and peripheral corneal thinning was noted, more marked on the right than the left. There was minimal evidence of inflammation with only slight hyperaemia of the sclera in the area adjacent to the cornea. In February 1975 the cornea perforated ( Fig. 1 ) and was repaired with a peripheral annular corneoscleral graft. The initial result was satisfactory but 2 weeks after surgery the donor tissue became infiltrated with inflammatory cells. It was thought that the appearance was consistent with an acute homograft reaction. In order to keep the donor tissue in position, a conjunctival pedicle flap was fashioned and sutured over the grafted area. Further melting of central corneal tissue occurred at the edge of the conjunctival flap.
Similar corneal thinning developed in the left eye ( Fig. 2 ) which failed to respond to intensive local therapy including subconjunctival heparin but not steroids. Eventually the cornea perforated with prolapse of the iris. In April 1975 this was repaired by mobilizing a flap from the adjacent sclera and overlaying this with a conjunctival bridge flap. In November 1975 the scleral flap retracted and perforation seemed imminent. During these surgical procedures, peripheral corneal melting progressed Ulceration of the cornea in rheumatoid arthritis 429 remorselessly in both eyes despite 2-hourly treatment with 1-cysteine eye drops.
Although the rheumatoid arthritis seemed completely inactive, she was started on azathioprine 50 mg bd (2-5 mg/kg) and her progress was closely followed by slit lamp examinations. Over the succeeding weeks the melting ceased, and by June 1976 re-epithelialization and stromal regeneration had occurred over the previously repaired iris prolapse in the left cornea (Fig. 3) In May 1976 he presented to the ophthalmic department with marginal thinning of the superior part of the right cornea. There was some associated vascularization and patchy inflammatory cell infiltration. In contrast to the 2 patients already described, there was an active scleritis adjacent to the corneal disease (Fig. 4) (Fig. 6) . On repeated observations the corneal melting was not progressive, and, in view of his age and general infirmity, positive therapy was not thought indicated. He is being followed up at frequent intervals.
CASE 5
This 82-year-old man was referred to the ophthalmic clinic with bilateral corneal thinning. Although he had no rheumatic complaints examination did show changes of trivial inactive polyarthritis affecting the MCP joints of both hands and both knees with rheumatoid nodules over both elbows. Plasma viscosity, haemoglobin, and white cell count were normal; rheumatoid factor, antinuclear factor, and other autoantibodies were absent.
The limbal guttering involved the whole of the periphery of each cornea, and in the right eye there was a marked degree of melting on the nasal side. There weie many punctate inflammatory cell infiltrates in the stroma on each side and some episcleral hyperaemia on the nasal Fide of the right cernea. He had previously shown an adverse response to topical steroid drops, in that they had apparently increased the melting process. Other local therapy had not helped. In view of this, treatment with azathioprine 175 mg/day (2-5 mg/kg) was introduced for a period of 2 months. Though the immediate clinical response was not dramatic, there was eventual improvement, with disappearance of the conjuctival hyperaemia and corneal Discussion Damage to the cornea in rheumatoid arthritis may result from an adjacent scleritis with sclerosing keratitis-peripheral inflammatory cell infiltration and vascularization followed by permanent scarring-localized to the site nearest the inflamed sclera (McGavin et al., 1976) . Limbal guttering occurs in association with rheumatoid scleritis, but may also develop in the apparent absence of scleral inflammation. It is possible that in some of these patients the scleritis was suppressed by local or systemic steroids. Patients may present with marginal thinning with no inflammatory changes except for a few dilated adjacent blood vessels (Watson, 1975 (Brown and Grayson, 1968) .
In patients with scleritis associated with rheumatoid arthritis the arthritis is usually severe with nodules and erosions with positive tests for rheumatoid factor and a low haemoglobin. Extra-articular manifestations of rheumatoid disease, particularly vasculitis, are common (Jayson and Jones, 1971 ). In contrast, the patients in this series showed a wide range of expression of rheumatoid disease, but in some, although there were advanced deformities, the arthritis was inactive without systemic manifestations and with negative tests for rheumatoid factor.
The relationship of keratolysis with Sjogren's syndrome is confused. Bloch et al. (1965) found a history of corneal ulceration in 3 of 63 patients with Sjogren's syndrome. Gudas et al. (1973) found one case, and Krachmer and Laibson (1974) recorded 6 patients with this combination. Some of the patients in the present series showed evidence of reduced lacrimal secretion but in none was tear production totally absent, whereas many patients with Sjogren's syndrome have much more severe limitation of tear formation without corneal ulceration. There are commonly other clinical manifestations of Sjogren's syndrome, such as xerostomia, but none was found in the present series. Moreover, a variety of autoantibodies are found in Sj6gren's syndrome patients, but these tests were usually negative in the patients with keratolysis. Circulating antibodies to corneal tissue have been found in patients with idiopathic comeal ulceration-Mooren's ulcer (Schaap et al., 1969) . Whether this is relevant to the corneal lesions in association with rheumatoid arthritis is uncertain.
Two types of pathological change have been Ulceration of the cornea in rheumatoid arthritis 431 described in patients with marginal guttering (Iwamoto et al., 1972) . The first is inflammatory with marked vascularization in and around the corneal lesion and dilatation of the adjacent conjunctival blood vessels. Often these patients are treated with local steroid eye drops which reduce the inflammation, but the cornea continues to melt away. Electron microscopy of the cornea shows changes resembling hypersensitivity reactions with accumulation of lymphocytes, neutrophils, and oedema, and fibrinoid necrosis of small blood vessels. The second type is the so-called quiescent group, with much less vascularization and no evidence of inflammation. The electron microscopic appearances show fatty degenerative changes in the stroma. This description of the pathological changes must be compared with the classification of Aronson et al. (1970) who suggested that inflammatory diseases of the cornea could be separated into an infiltrative group secondary to some inflammatory process, and an ischaemic group which they divided into a primary subgroup which followed obstruction of blood vessels, possibly by deposition of immune complexes and intravascular clotting, and a secondary group following infection, trauma, or chemical damage.
There is now good evidence that whatever the cause, the melting of the cornea is mediated by collagenases. Berman et al. (1971) showed the production of collagenases in rabbit eyes, and subsequently (Berman et al., 1973a) in human material. These enzymes cleave the tropocollagen molecule into two components containing threequarters and one-quarter of the original molecule respectively. It seems that corneal fibroblasts can produce a proenzyme which is activated by lysosomal enzymes or trypsin to develop collagenolytic activity (Hook et al., 1973) . This collagenase activity is inhibited by ac-2 macroglobulins with which they form complexes (Berman et al., 1975) . It is of interest that some ophthalmolgists think that serum will inhibit corneal ulceration as ac-2 macroglobulins are present in serum (Berman et al., 1973b) . oc-2 macroglobulins are normally present in tears, perhaps explaining the association of marginal degeneration with reduced tear production and why the corneal ulceration was not relieved by the use of artificial tears. Berman et al. (1973b) experimentally found a relationship between a-2 macroglobulin activity in tears and the extent of corneal ulcers.
With regard to treatment of corneal ulceration, the evidence is confused by the failure to examine separately corneal ulceration of different causes. Hook et al. (1973) thought that local steroids would potentiate collagenolytic activity, so promoting keratolysis. Several of the patients in the present series had received steroids systemically and locally, and it is not possible to know whether this produced or exacerbated the corneal disease or whether it was simply the patients with most severe disease who were receiving more aggressive forms of therapy. It is our impression that topical steroids had a deleterious effect in one patient and are contraindicated over a long period. However, in one patient improvement only occurred with local steroid therapy. Understanding of the part played by collagenases in the pathogenesis of corneal melting has led to trials of cysteine, acetylcysteine, and penicillamine drops locally (Slansky and Dohlman, 1970; Francois et al., 1973; Mehra and Singh, 1975) as they are thought to inhibit collagenase activity. Although these agents seem effective in experimental trials, they proved disappointing in the present study. Elliott et al. (1972) proposed the use of local heparin for peripheral corneal ischaemic lesions. In the one patient who received this treatment, we found it of no value. In any event, on theoretical grounds it seems unlikely to help. A further form of therapy is to apply contact lenses which protect the ulcerated area and act as an artificial epithelium. They may lead to healing of the defect beneath.
Operative measures may not be successful. It is well known that peripheral ulceration can recur in patients who have cornea scleral replacements (Watson, 1975) , and in addition an enhanced rejection of donor tissue has been noted. Attempts have also been made to cover corneal perforations with conjunctival flaps or scleral autografts, but the results have not been encouraging. Many such procedures result in visual loss. However, a report of good healing in several types of progressive marginal ulceration after excision and recession of adjacent limbal conjunctiva has recently appeared (Wilson et al., 1976) . We feel that iris prolapse is not necessarily an indication for surgery, as a thin layer of corneal tissue can reform over the knuckle of iris and afford protection against pathogenic microorganisms.
We found 3 patients with progressive disease which came under control only when systemic therapy was started with azathioprine or penicillamine. In one patient with scleritis and corneal ulceration there was no response to azathioprine. In any uncontrolled small series of this type it is impossible to draw valid conclusions, but we suggest that with incipient or repeated perforation of the cornea it is worth trying these agents. 
